Treating mice with TRX inhibits the development of airway inflammation and the overproduction of macrophage inflammatory protein (MIP)-1, RANTES, IL-4, and IL-5, which are responsible for the development of allergic inflammatory responses [22,23]. This evidence concerns the gene TXN and inflammatory response.